DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years

The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on 12.05.2021.

M/s Bharat Biotech International Ltd., Hyderabad (BBIL) had proposed to carry out a Phase- II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers.

In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28.

As rapid regulatory response, the proposal was deliberated in Subject Expert Committee (SEC) (COVID-19) on 11.05.2021. The Committee after detailed deliberation recommended for grant of permission to conduct proposed Phase II/III clinical trial to certain conditions.

1. GANDHI MEDICAL COLLEGE, SECUNDERABAD
Type of Test: RT-PCR

2. OSMANIA MEDICAL COLLEGE, HYDERABAD
Type of Test: RT-PCR

3. SIR RONALD ROSS OF TROPICAL & COMMUNICABLE DISEASES, HYDERABAD
Type of Test: RT-PCR

We are all trying hard to succeed in our life.  However, we are not able to find sufficient funds to start a business. Here a list of low investment small business ideas that can help you to succeed in your life 

 

BLOOD BANKS   Vizag Blood Banks   - NTR Blood Bank, Ramnagar: +918912565858 - Rotary Blood Bank, Jagdamba Plasm
VISAKHAPATNAM COVID -19 HOSPITALS LIST and Contact numbers
 
GOVERNMENT TB-HOSPITAL MOBILE NO: 0891-2552525
Oxygen Cylinders: